Right portal vein thrombosis from idiopathic cause: case report





Thrombosis; Portal Vein; Case report.


The aim of this study was to describe the case report of a 33-year-old girl with portal vein thrombosis. J.S.D.F., 33 years old, female, previously healthy, with a personal and family history negative for thromboembolic phenomena, without comorbidities, started with severe abdominal pain in the mesogastric region, radiating to HCD and back, associated with vomiting. Smoking active for about 20 years and using OC for 2 years. In view of the symptoms, she sought emergency services, where the first suspicion would be pancreatitis. Initial tests plagued leukocytosis. GUS of the total abdomen with doppler and CT of the abdomen showed the presence of thrombus in the right portal vein, with no other alterations. Rocefin® and metronidazole as an initial measure in the service began in addition to full coagulation with Clexane®. It showed clinical and laboratory improvement, with a reduction of leukocytes. The patient remained hospitalized in a hospital for 22 days to investigate the etiological cause. After of hospitalization, the patient was released with medical discharge, with guidelines for seeking the hematology service. During the investigation consultations, the results of the requested tests were negative for the diagnostic suspicions of nocturnal paroxysmal hemoglobinuria and chronic myeloproliferative disease. After 6 months of follow-up, she was discharged from the hematology service because she did not present a suspected disease and classified the cause of thrombolytic event as idiopathic associated with the combined use of OC and smoking.

Author Biographies

Júlia Siqueira Fernandes Silveira, Faculdade Pernambucana de Saúde

Medical Student at the Pernambuco Faculty of Health.

Michelle Pereira de Faria e Silva, Faculdade de Medicina de Olinda

Medicine student at School of Medicine of Olinda.

Camila Brandão Leal Pereira, Instituto Metropolitano do Ensino Superior

Student of Medicine at Metropolitan Institute of Higher Education/IMES-UNIVAÇO.

Roberta Lara Napoleão Nogueira, Instituto Metropolitano do Ensino Superior

Student of Medicine at Metropolitan Institute of Higher Education/IMES-UNIVAÇO

Lays Santana de Freitas, Faculdade Pernambucana de Saúde

Student of Medicine at Pernambuco College of Health.

Lise Reis Melo, Universidade Federal da Paraíba

Mastologist at Hospital Univesirty Lauro Wanderley / Federal UNversiity of Paraíba

Joelmir Lucena Veiga da Silva, Faculdade de Medicina de Olinda

Professor at School of Medicine of Olinda.


Alves, R. L. J., Macedo, F. A., Latorre, M. V., Paula, B. H. R., Barradas, F., & Tavares, M. (2012). Trombose de veia porta: revisão de literatura e relato de caso. Cadernos UniFOA, 18, 101-108. doi:10.47385/cadunifoa.v7i18.1096

Balfour, G. W., & Stewart, T. G. (1869). Case of enlarged spleen complicated with ascites, both depending upon varicose dilatation and thrombosis of the portal vein. Edinburgh Medical Journal, 14(7), 589-598.

Belli, L., Romani, F., Riolo, F., Rondinara G., Aseni, P., Di Stefano, M., Contorni, L., & Bini, M. (1989). Thrombosis of portal vein in absence of hepatic disease. Surgery, Gynecology & Obstetrics, 169(1), 46-49.

Brandão, G. M. S, Cândido, R. C. F, Rollo, H. de A., Sobreira, M. L., & Junqueira, D. R. (2018). Direct oral anticoagulants for treatment of deep vein thrombosis: Overview of systematic reviews. Jornal Vascular Brasileiro, 17(4), 310-317. doi:10.1590/1677-5449.005518

Cruz, S. L. A. da, Bottega, D. dos S., & Paiva, M. J. M. de. (2021). Oral contraceptive: side effects and its relationship with venous thrombosis. Research, Society and Development, 10(14), e283101421798. doi:10.33448/rsd-v10i14.21798

Godoy, J. M. P, Godoy, M. F., Ricci, O., & Ruiz, M. A. (1999). Hipercoagulabilidade e tromboses. Revista Brasileira de Hematologia e Hemoterapia, 21(3): 127-134.

Gonçalves, M. L. et al. (2002). Trombose da veia porta e mutação G20210A da protrombina: A Propósito de um Caso Clínico. GE - Jornal Português de Gastrenterologia, 9, 40-44.

Junge, W., Mellinger, U., Parke, S., & Serrani, M. (2011). Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open‐label, single‐centre study. Clinical Drug Investigation, 31(8), 573-584. doi:10.2165/11590220-000000000-00000

Mahmoud, A., Elias, E., & Baeauchamp, N. (1997). Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut, 40(6), 798-800. doi:10.1136/gut.40.6.798

Merck, M. (2007). Manual Merck de Medicina: diagnóstico e tratamento. 17 ed. São Paulo: Roca, 2007.

Moreira, A. M., Rabenhorst, S. H. B., Holanda, R. A. R. R., & Pitombeira, M. H. (2009). Fatores de risco associados a trombose em pacientes do estado do Ceará. Revista Brasileira de Hematologia e Hemoterapia, 31(3), 132-136, 2009. doi:10.1590/S1516-84842009005000044

Mota, L. P., Sousa, M. V. A. de, Gonçalves, J. N. de A., Leal, N. T. B., Leal, L. B., Negreiros, A. L. B., Silva, D. H. da, Penha, A. A. G. da, Alves, N. S., Ferreira, P. de F., Leal, G. L., Sousa, F. de A. da S., Freitas, F. V. da S., Silveira Filho, E. R. da, Costa, J. D. da, Carvalho, M. M. de, Pereira, M. G. de C.,

Pereira, S. A., & Santos, J. M. F. dos. (2021). Development of thrombosis in patients with SARS-CoV-2 infection. Research, Society and Development, 10(9), e52210918246. doi:10.33448/rsd-v10i9.18246

Muguet, C. M., Guimarães, K., Bastos, L., Baroni, M., Curty, M., Marzano, M., Costa, M., Tardelli, M., Risi, R., Lustosa, R., & Estato, V. (2022). Post-COVID-19 deep vein thrombosis and its pharmacological management. Research, Society and Development, 11(1), e12311124991. doi:10.33448/rsd-v11i1.24991

Nutescu E. A., Burnett A., Fanikos, J., Spinler, S., & Wittkowsky, A. (2016). Pharmacology of

anticoagulants used in the treatment of venous thromboembolism. Journal of Thrombosis and Thrombolysis, 41(1), 15-31. doi:10.1007/s11239-015-1314-3

Okuda, K., Ohnishi, K. & Kimura, K. (1985). Incidence of portal vein thrombosis in liver cirrhosis: An angiographic study in 708 patients. Gastroenterology, 89(2), 279-286. doi:10.1016/0016-5085(85)90327-0

Ortega, M. Q., Cruz, R. S., Bernardi, L. G., Braga, M. E. D., & Dominato, A. A. G. (2020). Thrombotic effects on users of combined oral contraceptives throughout their fertile life: integrative review. Research, Society and Development, 9(11), e77091110458. doi:10.33448/rsd-v9i11.10458

Padovan, F. T., & Freitas, G. (2015). Anticoncepcional oral associado ao risco de trombose venosa profunda. Brazilian Journal of Surgery and Clinical Research, 9(1), 73-77.

Pereira, A. S., Shitsuka, D. M., Parreira, F. J. & Shitsuka, R. (2018). Metodologia da pesquisa científica [recurso eletrônico]. Santa Maria, RS: UFSM, NTE.

Rott, H. (2012). Thrombotic risks of oral contraceptives. Current Opinion in Obstetrics and Gynecology, 24(4), 235-240. doi:10.1097/GCO.0b013e328355871d

Tavares, L. da S., & Ortiz, J. V. (2021). Development of thrombosis in patients with and without SARS-Cov-2 infection - literature review. Research, Society and Development, 10(15), e410101522959. doi:10.33448/rsd-v10i15.22959

Tzankova, V, Petrov, V, & Danchev, N. (2010). Impact of oral contraceptives and smoking on arterial and deep venous thrombosis: a retrospective case‐control study. Biotechnology & Biotechnological Equipment, 24(3), 2026-2030. doi:10.2478/V10133-010-0054-Y




How to Cite

SILVEIRA, J. S. F.; SILVA, M. P. de F. e .; PEREIRA, C. B. L.; NOGUEIRA, R. L. N.; FREITAS, L. S. de; MELO, L. R.; SILVA, J. L. V. da. Right portal vein thrombosis from idiopathic cause: case report. Research, Society and Development, [S. l.], v. 11, n. 2, p. e38311225833, 2022. DOI: 10.33448/rsd-v11i2.25833. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/25833. Acesso em: 21 feb. 2024.



Health Sciences